Clinical Trial Update: The Predictive Value of Complement C3 in Patients With Advanced Gastric Cancer

View source ↗

Summary

This completed clinical trial assesses whether Complement C3 levels can predict outcomes in patients with advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Gastric Cancer, Complement Component Deficiency | Status: COMPLETED